These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23321062)

  • 1. Early stage uterine serous carcinoma: management updates and genomic advances.
    Fader AN; Santin AD; Gehrig PA
    Gynecol Oncol; 2013 Apr; 129(1):244-50. PubMed ID: 23321062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine papillary serous cancer: a review of the literature.
    del Carmen MG; Birrer M; Schorge JO
    Gynecol Oncol; 2012 Dec; 127(3):651-61. PubMed ID: 23000148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular alterations in uterine serous carcinoma.
    Hayes MP; Ellenson LH
    Gynecol Oncol; 2010 Feb; 116(2):286-9. PubMed ID: 20109727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel targeted therapies in uterine serous carcinoma, an aggressive variant of endometrial cancer.
    Menderes G; Clark M; Santin AD
    Discov Med; 2016 Apr; 21(116):293-303. PubMed ID: 27232515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based treatment and outcomes of Stage I uterine serous carcinoma.
    van der Putten LJ; Hoskins P; Tinker A; Lim P; Aquino-Parsons C; Kwon JS
    Gynecol Oncol; 2014 Jan; 132(1):61-4. PubMed ID: 24219983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management.
    Fader AN; Boruta D; Olawaiye AB; Gehrig PA
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):21-9. PubMed ID: 19952744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.
    Desai NB; Kollmeier MA; Makker V; Levine DA; Abu-Rustum NR; Alektiar KM
    Gynecol Oncol; 2014 Oct; 135(1):49-53. PubMed ID: 25084509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in the Management of Early-stage Serous Endometrial Cancer.
    Larish A; Mariani A; Langstraat C
    In Vivo; 2021; 35(2):671-680. PubMed ID: 33622859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006.
    Tchabo NE; McCloskey S; Mashtare TL; Andrews C; Singh AK; Mhawech-Fauceglia P; Odunsi K; Lele S; Jaggernauth W
    Gynecol Oncol; 2009 Nov; 115(2):249-56. PubMed ID: 19692115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates in therapy for uterine serous carcinoma.
    Roque DM; Santin AD
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):29-37. PubMed ID: 23138439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review.
    Boruta DM; Gehrig PA; Fader AN; Olawaiye AB
    Gynecol Oncol; 2009 Oct; 115(1):142-153. PubMed ID: 19592079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.
    Black JD; English DP; Roque DM; Santin AD
    Womens Health (Lond); 2014 Jan; 10(1):45-57. PubMed ID: 24328598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers.
    Bellone S; McNamara B; Mutlu L; Demirkiran C; Hartwich TMP; Harold J; Yang-Hartwich Y; Siegel ER; Santin AD
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis.
    Rabban JT; Zaloudek CJ
    Pathology; 2007 Feb; 39(1):125-33. PubMed ID: 17365828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.
    Sagae S; Susumu N; Viswanathan AN; Aoki D; Backes FJ; Provencher DM; Vaughan M; Creutzberg CL; Kurzeder C; Kristensen G; Lee C; Kurtz JE; Glasspool RM; Small W
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S83-9. PubMed ID: 25341586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study.
    Erickson BK; Najjar O; Damast S; Blakaj A; Tymon-Rosario J; Shahi M; Santin A; Klein M; Dolan M; Cimino-Mathews A; Buza N; Ferriss JS; Stone RL; Khalifa M; Fader AN
    Gynecol Oncol; 2020 Oct; 159(1):17-22. PubMed ID: 32709539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
    Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE
    Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of resistance to HER2-targeted therapies in HER2-amplified uterine serous carcinoma, and strategies to overcome it.
    Menderes G; Lopez S; Han C; Altwerger G; Gysler S; Varughese J; Schwartz PE; Santin AD
    Discov Med; 2018 Aug; 26(141):39-50. PubMed ID: 30265854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
    Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE
    Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.